← Eichor
Study identifier: NCT06749899 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

Condition: Nasopharyngeal Cancinoma (NPC) · Nasopharyngeal Cancer  ·  Sponsor: Sun Yat-Sen University Cancer Center

PhasePhase 3
Planned participants580
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The trial aimed to compare QL1706 combined with induction chemotherapy plus concurrent chemoradiotherapy (IC+CCRT) versus IC+CCRT alone in High-risk Locoregionally-Advanced Nasopharyngeal Carcinoma (LANPC).

This description comes directly from the study's public registry record.

Talk to the study team

Jun Ma, M.D.  ·  +862087343469  ·  majun2@mail.sysu.edu.cn

Rui Guo, M.D.  ·  guorui@sysucc.org.cn

Always discuss trial participation with your own doctor first.

Locations (19)

Fujian Cancer HospitalFuzhou, Fujian, ChinaNot Yet Recruiting
Dongguan People's HospitalDongguan, Guangdong, ChinaNot Yet Recruiting
First People's Hospital of FoshanFoshan, Guangdong, ChinaNot Yet Recruiting
Guangzhou Panyu Central HospitalGuangzhou, Guangdong, ChinaNot Yet Recruiting
Sun Yat-Sen University Cancer CenterGuangzhou, Guangdong, ChinaRecruiting
Zhongshan People's HospitalZhongshan, Guangdong, ChinaNot Yet Recruiting
Cancer Hospital of Guangxi Medical UniversityNanning, Guangxi, ChinaNot Yet Recruiting
Cancer Hospital of Guizhou Medical UniversityGuiyang, Guizhou, ChinaNot Yet Recruiting
Hubei Province Cancer HosiptalWuhan, Hubei, ChinaNot Yet Recruiting
Renmin Hospital of Wuhan UniversityWuhan, Hubei, ChinaNot Yet Recruiting
Tongji Hospital Affiliated with Tongji Medical College of Huazhong University of Science and TechnologyWuhan, Hubei, ChinaNot Yet Recruiting
Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and TechnologyWuhan, Hubei, ChinaNot Yet Recruiting

+ 7 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06749899